Overall Status

Recruiting (2)

Active, not recruiting (1)

Not yet recruiting (1)

Phase

early phase 1 (1)

phase 1 (1)

phase 2 (1)

phase 3 (1)

Sponsor

Alliance for Clinical Trials in Oncology (1)

M.D. Anderson Cancer Center (1)

Mayo Clinic (1)

National Cancer Institute (NCI) (1)

Collaborator

National Cancer Institute (NCI) (2)

Study Documents

Intervention Type

drug (4)

biological (3)

procedure (2)

other (1)

Funder Type

Other (3)

NIH (1)

Study Type

Interventional (4)

unresectable gastric adenocarcinoma

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma Trial

Not yet recruiting

Advanced Esophageal Adenocarcinoma
+14 more

Fluorouracil
+8 more

(no location specified)

Jan 3, 2023

Clinical Stage III Gastric Cancer AJCC v8, Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage

Active, not recruiting

Clinical Stage III Gastric Cancer AJCC v8
+7 more

Berzosertib
+4 more

Duarte, California
+30 more

Jan 7, 2023

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

Recruiting

Anatomic Stage III Breast Cancer AJCC v8
+129 more

Cyclophosphamide
+3 more

Jacksonville, Florida

Mayo Clinic in Florida

Apr 8, 2022

Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma, Clinical Stage III Gastric Cancer AJCC v8

Recruiting

Advanced Gastric Adenocarcinoma
+32 more

Lenvatinib
Pembrolizumab

Houston, Texas

M D Anderson Cancer Center

Mar 2, 2022